Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation

Saved in:
Bibliographic Details
Published in:Chin Med J (Engl)
Main Authors: Chen, Si-Si, Sun, Qian, Cao, Lan, Wu, Wen-Zhong, Xie, Yue, Qiao, Chun, Li, Jian-Yong, Qian, Si-Xuan, Hong, Ming
Format: Artigo
Language:Inglês
Published: Lippincott Williams & Wilkins 2021
Subjects:
Clinical Observations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8213253/
https://ncbi.nlm.nih.gov/pubmed/33323826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CM9.0000000000001316
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items